POSTMENOPAUSAL OSTEOPOROSIS

这项研究旨在比较两种药物的有效性。Fosamax（阿仑膦酸钠片）和Miacalcin（降钙素鲑鱼）鼻喷雾剂。 目前在美国用于治疗绝经后骨质疏松症，并评估其治疗的安全性和耐受性。 如果需要，所有患者还将接受维生素D和钙补充剂。 钙是健康骨骼的必需营养素;许多临床研究表明，增加钙的摄入量可以保护骨骼免受进一步的骨质流失。 约320名绝经后女性将入组本研究。

This study is designed to compare the effectiveness of two medications. Fosamax (alendronate sodium tablets) and Miacalcin (calcitonin-salmon) Nasal Spray. Currently prescribed in the United States for treatment of postmenopausal osteoporosis, and to assess safety and tolerability of their treatments. All patients will also receive Vitamin D and calcium supplements, if needed. Calcium is an essential nutrient for healthy bones; many clinical studies have shown that increasing calcium intake may protect the skeleton from further bone loss. Approximately 320 postmenopausal women will be entered into this study.